We first provided evidence that SET8 is highly expressed in HCC tumor tissues and from the TCGA cohort, we demonstrate that SET8 is positively correlated with overall survival and is an independent predictor in HCC patients. This evidence concerns the gene KMT5A and hepatocellular carcinoma.